REQUEST A DEMO
Total
USD $0.00
Search more companies

Exir Pharmaceutical Company Public Joint Stock (Iran)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Exir Pharmaceutical Company Public Joint Stock Profile Updated: June 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Exir Pharmaceuticals Company is a pharmaceutical manufacturer that offers a range of pharmaceutical finished forms, including tablets, capsules, ampoules, cartridges, syrups, and injectable vials. Exir Pharmaceuticals Company exports its products to over 18 countries and claims to utilize new technologies and up-to-date knowledge to provide high-quality pharmaceutical products at competitive prices.

Legal Address
18 Km Of Tehran-Karaj Special Road, Darupakhsh Street, Door No. 2 (Door Of The Houses) Of The Pharmaceutical Factor
Tehran; Tehran; Postal Code: 1397116396

Contact Details: Purchase the Exir Pharmaceutical Company Public Joint Stock report to view the information.

Website: http://www.exir.co.ir

Basic Information
Total Employees:
Purchase the Exir Pharmaceutical Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Exir Pharmaceutical Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Exir Pharmaceutical Company Public Joint Stock report to view the information.
Incorporation Date:
1985
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Exir Pharmaceutical Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
16.56%
Total operating revenue
16.68%
Operating profit (EBIT)
-2.7%
EBITDA
-2.93%
Net Profit (Loss) for the Period
-8.6%
Total assets
12.99%
Total equity
26.97%
Operating Profit Margin (ROS)
-7.54%
Net Profit Margin
-6.47%
Return on Equity (ROE)
-18.07%
Debt to Equity Ratio
-49.49%
Quick Ratio
0.03%
Cash Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?